Carbidopa, Levodopa

3 trials NNeurology/Psychiatry

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

0 Recruiting

2 Completed trials

2 Sponsors

10 Countries

Phase III

Phase II

Phase IV

Phase III: 1 Phase II: 1 Phase IV: 1

Indications tested

Parkinson's disease 2

Sponsors using this IMP

Neuroderm Ltd. 2 Navamedic AB 1

All trials

3 total

Patient Evaluation of OraFID, a New Medicine Dispenser and App for Flexilev minitablets Pending

2025-524296-23-01 Phase IV 1 country Navamedic AB
A clinical study to investigate the efficacy, safety, and tolerability of continuous subcutaneous ND0612 infusion in comparison to oral trea… Ended

2024-511940-20-00 Phase III 9 countries Neuroderm Ltd.
A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson’s Disease (BeyoND) Ended

2024-513548-27-00 Phase II 4 countries Neuroderm Ltd.

Showing 1–3 of 3 trials

← All drugs A–Z